LINC01348

Across TCGA pan-cancer cohorts, LINC01348 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated LINC01348 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher LINC01348 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC01348 expression acts as an unfavorable survival marker, although some lineages such as READ and HNSC show a favorable association.

READ, HNSC, and CHOL are the cancer types where LINC01348 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	All	0.893	0.271	.002	50	view →
HNSC	DFS	Quartile	II,III,IV	0.794	0.528	.001	46	view →
CHOL	DFS	Tertile	II,III,IV	0.117	0.626	.001	30	view →
MESO	OS	Tertile	All	0.279	0.525	.002	30	view →
PAAD	OS	Quartile	II,III,IV	0.583	0.300	.001	27	view →
LGG	OS	Tertile	All	0.844	0.939	<.001	18	view →
BLCA	DFS	Median	IV	0.326	0.103	.008	17	view →
BRCA	DFS	Median	IV	0.303	0.726	.004	16	view →
UCEC	OS	Tertile	All	0.915	0.952	.019	16	view →
THCA	OS	Tertile	IV	0.513	0.855	.017	15	view →
COAD	OS	Tertile	All	0.749	0.880	.018	13	view →
STAD	OS	Tertile	IV	0.506	0.179	.017	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

LINC01348–READ (DFS)

Open the READ breakdown →